MAPK1 and rheumatoid arthritis: This article aims to present a comprehensive overview of the MAPK/ERK pathway’s mechanistic involvement in RA and to highlight the potential of pathway-targeted strategies for therapeutic intervention, thereby appealing to scientists or clinicians working in rheumatology and immunology and guiding their future research directions in the identification of novel targets for RA treatment.